Parents' Experiences of Expanded Newborn Screening Evaluations

被引:58
作者
DeLuca, Jane M. [1 ]
Kearney, Margaret H. [1 ]
Norton, Sally A. [1 ]
Arnold, Georgianne L. [2 ]
机构
[1] Univ Rochester, Sch Nursing, Rochester, NY 14642 USA
[2] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Div Med Genet, Pittsburgh, PA USA
关键词
metabolic disorders; inborn errors of metabolism; primary health care; genetics; newborn screening; public health; qualitative research; CYSTIC-FIBROSIS; INFORMING PARENTS; FOLLOW-UP; BAD-NEWS; HEALTH; CARE; DEFICIENCY; DISORDERS; GENETICS; OUTCOMES;
D O I
10.1542/peds.2010-3413
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVE: Abnormal results of newborn screening for common metabolic diseases are known to create substantial distress for parents. We explored parents' perceptions during diagnostic evaluations for newer disorders that are less well understood. METHODS: Thirty families completed 48 open-ended interviews before and/or after parents received confirmatory test results for their infants. Qualitative content analysis was used to analyze the data. RESULTS: Parents were shocked by the notification of the abnormal test result. Their urgent and often frustrating searches for information dominated the early phase of the screening process. Treatment center personnel were mainly informative and reassuring, but waiting for results exacerbated parents' distress. Equivocal results from diagnostic testing created uncertainties for parents regarding their infants' long-term health. After counseling, some parents reported inaccurate ideas about the disorders despite exposure to large amounts of information. Regardless of the challenges and anxieties of the evaluation, nearly every parent thought newborn screening was an important program for infant health. CONCLUSIONS: The evaluation of a newborn for an abnormal screening result was highly stressful for parents. To help reduce parents' distress, improvements in communications and clinical services are needed. Recommendations of useful Internet sites and discussions of this information may benefit parents. Tailoring counseling to meet the needs of culturally and educationally diverse families is needed. Families and infants with equivocal results are a new group of patients who merit comprehensive clinical follow-up. Pediatrics 2011; 128: 53-61
引用
收藏
页码:53 / 61
页数:9
相关论文
共 64 条
[11]   Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children [J].
Calonge, Ned ;
Green, Nancy S. ;
Rinaldo, Piero ;
Lloyd-Puryear, Michele ;
Dougherty, Denise ;
Boyle, Coleen ;
Watson, Michael ;
Trotter, Tracy ;
Terry, Sharon F. ;
Howell, R. Rodney .
GENETICS IN MEDICINE, 2010, 12 (03) :153-159
[12]   Attitudes about genetics in underserved, culturally diverse populations [J].
Catz, DS ;
Green, NS ;
Tobin, JN ;
Lloyd-Puryear, MA ;
Kyler, P ;
Umemoto, A ;
Cernoch, J ;
Browne, R ;
Wolman, F .
COMMUNITY GENETICS, 2005, 8 (03) :161-172
[13]   Long-term Evaluation of Genetic Counseling Following False-Positive Newborn Screen for Cystic Fibrosis [J].
Cavanagh, Laura ;
Compton, Cecilia J. ;
Tluczek, Audrey ;
Brown, Roger L. ;
Farrell, Philip M. .
JOURNAL OF GENETIC COUNSELING, 2010, 19 (02) :199-210
[14]   Genetic counseling and neonatal screening for cystic fibrosis: An assessment of the communication process [J].
Ciske, DJ ;
Haavisto, A ;
Laxova, A ;
Rock, LZM ;
Farrell, PM .
PEDIATRICS, 2001, 107 (04) :699-705
[15]   Incidence of Fragile X Syndrome by Newborn Screening for Methylated FMR1 DNA [J].
Coffee, Bradford ;
Keith, Krayton ;
Albizua, Igor ;
Malone, Tamika ;
Mowrey, Julie ;
Sherman, Stephanie L. ;
Warren, Stephen T. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2009, 85 (04) :503-514
[16]   Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency [J].
Comeau, Anne Marie ;
Hale, Jaime E. ;
Pai, Sung-Yun ;
Bonilla, Francisco A. ;
Notarangelo, Luigi D. ;
Pasternack, Mark S. ;
Meissner, H. Cody ;
Cooper, Ellen Rae ;
DeMaria, Alfred ;
Sahai, Inderneel ;
Eaton, Roger B. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 :S273-S281
[17]  
CYSTIC F, 2009, J PEDIAT, V155, P116
[18]   Newborn screening for Pompe disease by measuring acid α-glucosidase activity using tandem mass spectrometry [J].
Dajnoki, Angela ;
Muehl, Adolf ;
Fekete, Gyoergy ;
Keutzer, Joan ;
Orsini, Joe ;
Dejesus, Victor ;
Zhang, X. Kate ;
Bodamer, Olaf A. .
CLINICAL CHEMISTRY, 2008, 54 (10) :1624-1629
[19]   Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry [J].
Dajnoki, Angela ;
Fekete, Gyoergy ;
Keutzer, Joan ;
Orsini, Joseph J. ;
De Jesus, Victor R. ;
Chien, Yin-Hsiu ;
Hwu, Wuh-Liang ;
Lukacs, Zoltan ;
Muehl, Adolf ;
Zhang, X. Kate ;
Bodamer, Olaf .
CLINICA CHIMICA ACTA, 2010, 411 (19-20) :1428-1431
[20]   Recommendations for effective newborn screening communication: Results of focus groups with parents, providers, and experts [J].
Davis, TC ;
Humiston, SG ;
Arnold, CL ;
Bocchini, JA ;
Bass, PF ;
Kennen, EM ;
Bocchini, A ;
Kyler, P ;
Lloyd-Puryear, M .
PEDIATRICS, 2006, 117 (05) :S326-S340